Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art

Saudi Pharmaceutical Journal

Volumn 24, Issue 2, 2016, Pages 133-139

  Soni, Govind ^a   Yadav, Khushwant S ^a  

^a Rajeev Gandhi College of Pharmacy   (India)

Author keywords

Intracellular delivery; Nanogel carriers; PEGylated nanogels; SiRNA; Stimuli responsive nanogels; Tumor extracellular pH targeting

Indexed keywords

EID: 84898709206     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2014.04.001     Document Type: Review

References (54)

1. Ayame H., Morimoto N., Akioshi K. Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug. Chem. 2008, 19:882-890.
2. Bae K.H., Mok H., Park T.G. Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials 2008, 29:3376-3383.
3. Bromberg L. Intelligent hydrogels for the oral delivery of chemotherapeutics. Expert Opin. Drug Deliv. 2005, 2(6):1003-1013.
4. Chacko R.T., Ventura J., Zhuang J., Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv. Drug Deliv. Rev. 2012, 64(9):836-851.
5. Chen D., Yu H., Sun K., Liu W., Wang H. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery. Drug Deliv. 2013, (posted online on October 9, 2013). 10.3109/10717544.2013.838717.
6. Chiang W.H., Ho V.T., Huang W.C., Huang Y.F., Chern C.S., Chiu H.C. Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release. Langmuir 2012, 28(42):15056-15064.
7. Choi J.H., Jang J.Y., Joung Y.K., Kwon M.H., Park K.D. Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A. J. Control. Release 2010, 147:420-427.
8. Cun D., Foged C., Yang M., Frøkjær S., Nielsen H.M. Preparation and characterization of poly (dl-lactide-co-glycolide) nanoparticles for siRNA delivery. Int. J. Pharm. 2010, 390(1):70-75.
9. Dickerson E.B., Blackburn W.H., Smith M.H., Kapa L.B., Lyon L.A., McDonald J.F. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer 2010, 10:10.
10. Duan C., Zhang D., Wang F., Zheng D., Jia L., Feng F., Liu Y., Wang Y., Tian K., Wang F., Zhang Q. Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting. Int. J. Pharm. 2011, 409:252-259.
11. Dykxhoorn D.M., Palliser D., Lieberman J. The silent treatment: siRNAs as small molecule drugs. Gene Ther. 2006, 13:541-552.
12. Gonçalves C., Pereira P., Gama M. Self-assembled hydrogel nanoparticles for drug delivery applications. Materials 2010, 3(2):1420-1460.
13. Huang S.J., Sun S.L., Feng T.H., Sung K.H., Lui W.L., Wang L.F. Folate-mediated chondroitin sulfate-Pluronic® 127 nanogels as a drug carrier. Eur. J. Pharm. Sci. 2009, 38:64-73.
14. Jayakumar R., Nair A., Rejinold N.S., Maya S., Nair S.V. Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells. Carbohydr. Polym. 2012, 87(3):2352-2356.
15. Kabanov A.V., Vinogradov S.V. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew. Chem. Int. Ed. 2009, 48:5418-5429.
16. Kim J.O., Oberoi H.S., Desale S., Kabanov A.V., Bronich T.K. Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery. J. Drug Target. 2013, (posted online on September 2, 2013). 10.3109/1061186X.2013.831421.
17. Lee H., Mok H., Lee S., Oh Y.K., Park T.G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J. Control. Release 2007, 119:245-252.
18. Lee E.S., Gao Z., Bae Y.H. Recent progress in tumor pH targeting nanotechnology. J. Control Release 2008, 132:164-170.
19. Li N., Wang J., Yang X., Li L. Novel nanogels as drug delivery systems for poorly soluble anticancer drugs. Colloids Surf. B 2011, 83:237-244.
20. Liechty W.B., Peppas N.A. Expert opinion: responsive polymer nanoparticles in cancer therapy. Eur. J. Pharm. Biopharm. 2012, 80:241-246.
21. Mao S., Sun W., Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 2010, 62:12-27.
22. Mimi H., Ho K.M., Siu Y.S., Wu A., Li P. Polyethyleneimine-based core-shell nanogels: a promising Sirna carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. J. Control. Release. 2012, 158:123-130.
23. Morinloto N., Qiu X.P., Winnik F.M., Akiyoshi K. Dual stimuli-responsive nanogels by self-assembly of polysaccharides lightly grafted with thiol-terminated poly(Nisopropylacrylamide) chains. Macromolecules 2008, 41:5985-5987.
24. Morrissey D.V., Blanchard K., Shaw L., Jensen K., Lockridge J.A., Dickinson B., McSwiggen J.A., Vargeese C., Bowman K., Shaffer C.S., Polisky B.A., Zinnen S. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 2005, 41:1349-1356.
25. Murphy E.A., Majeti B.K., Mukthavaram R., Acevedo L.M., Barnes L.A., Cheresh D.A. Targeted nanogels: a versatile platform for drug delivery to tumors. Mol. Cancer Ther. 2011, 10(6):972-982.
26. Na K., Lee E.S., Bae Y.H. Self-organized nanogels responding to tumor extracellular ph: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells. Bioconjug. Chem. 2007, 18:1568-1574.
27. Naeye B., Raemdonck K., Remaut K., Sproat B., Demeester J., De Smedt S.C. PEGylation of biodegradable dextran nanogels for siRNA delivery. Eur. J. Pharm. Sci. 2010, 40:342-351.
28. Oerlemans C., Bult W., Bos M., Storm G., Nijsen J.F.W., Hennink W.E. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm. Res. 2010, 27(12):2569-2589.
29. Oh J.K., Siegwart D.J., Lee H.I., Sherwood G., Peteanu L., Hollinger J.O., Kataoka K., Matyjaszewski K. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation. J. Am. Chem. Soc. 2007, 129:5939-5945.
30. Oh N.M., Oh K.T., Baik H.J., Lee B.R., Lee A.H., Youn Y.S., Lee E.S. A self-organized 3-diethylaminopropyl-bearing glycol chitosan nanogel for tumor acidic pH targeting: In vitro evaluation. Coll. Surf. B Biointerfaces 2010, 78:120-126.
31. Oliveira S., Storm G., Schiffelers R. Targeted delivery of siRNA. J. Biomed. Biotechnol. 2006, 1-9. Article ID: 63675. 10.1155/JBB/2006/63675.
32. Panyam J., Labhasetwar V. Targeting intracellular targets. Curr. Drug Deliv. 2004, 1(3):235-247.
33. Park W., Park S.J., Na K. Potential of self-organizing nanogel with acetylated chondroitin sulfate as an anti-cancer drug carrier. Colloids Surf. B Biointerfaces 2010, 79:501-508.
34. Peppas N.A., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50(1):27-46.
35. Qiao Z.Y., Zhang R., Du F.S., Liang D.H., Li Z.C. Multi-responsive nanogels containing motifs of ortho ester, oligo(ethylene glycol) and disulfide linkage as carriers of hydrophobic anti-cancer drugs. J. Control. Release 2011, 152:57-66.
36. Raemdonck K., Demeester J., De Smedt S. Advanced nanogel engineering for drug delivery. Soft Matter 2009, 5:707-715.
37. Raemdonck K., Naeye B., Buyens K., Vandenbroucke R.E., Hogset A., Demeester J., De Smedt S.C. Biodegradable dextran nanogels for RNA interference: focusing on endosomal escape and intracellular siRNA delivery. Adv. Funct. Mater. 2009, 19:1406-1415.
38. Raemdonck K., Naeye B., Høgset A., Demeester J., De Smed S.C. Prolonged gene silencing by combining siRNA nanogels and photochemical internalization. J. Control. Release 2010, 145:281-288.
39. Reischl D., Zimmer A. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine 2009, 5:8-20.
40. Rijcken C.J., Soga O., Hennink W.E., Van Nostrum C.F. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J. Control Release 2007, 120:131-148.
41. Shimoda A., Sawada S., Kano A., Maruyama A., Moquin A., Winnik F.M., Akiyoshi K. Dual crosslinked hydrogel nanoparticles by nanogel bottom-up method for sustained-release delivery. Colloids Surf. B: Biointerfaces 2012, 99:38-44.
42. Singha K., Namgung R., Kim W.J. Polymers in small-interfering RNA delivery. Nucleic Acid Ther. 2011, 21(3):133-147.
43. Soni G., Yadav K.S. High encapsulation efficiency of poloxamer-based injectable thermoresponsive hydrogels of etoposide. Pharm. Dev. Tech. 2014, 19(6):651-661.
44. Toita S., Sawada S., Akiyoshi K. Polysaccharide nanogel gene delivery system with endosome-escaping function: Co-delivery of plasmid DNA and phospholipase A2. J. Control. Release 2011, 155:54-59.
45. Vinogradov S.V. Colloidal microgels in drug delivery applications. Curr. Pharm. Des. 2006, 12(36):4703-4712.
46. Vinogradov S.V., Bronich T.K., Kabanov A.V. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv. Drug Deliv. Rev. 2002, 54:135-147.
47. Vinogradov S.V., Batrakova E.V., Kabanov A.V. Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 2004, 15:50-60.
48. Vinogradov S.V., Zeman A.D., Batrakova E.V., Kabanov A.V. Polyplex nanogel formulations for drug delivery of cytotoxic nucleoside analogs. J. Control. Release 2005, 107:143-157.
49. Xie F.Y., Woodle M.C., Lu P.Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov. Today 2006, 11:67-73.
50. Xiong W., Wang W., Wang Y., Zhao Y., Chen H., Xu H., Yang X. Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy. Coll. Surf B: Biointerfaces 2011, 84:447-453.
51. Yadav K.S., Jacob S., Sachdeva G., Chuttani K., Mishra A.K., Sawant K.K. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia. J. Microencapsulation 2011, 28(8):729-742.
52. Yadav K.S., Jacob S., Sachdeva G., Sawant K.K. Intracellular delivery of etoposide loaded biodegradable nanoparticles: cytotoxicity and cellular uptake studies. J. Nanosci. Nanotechnol. 2011, 11:6657-6667.
53. Yallapu M.M., Jaggi M., Chauhan S.C. Design and engineering of nanogels for cancer treatment. Drug Discovery Today 2011, 2011(16):457-463.
54. Zhang L., Guo R., Yang M., Jiang X., Liu B. Thermo and pH dual responsive nanoparticles for anti cancer drug delivery. Adv. Mater. 2007, 19:2988-2992.